Anuv Ratan

Managing Director Health Care Strategic Growth Menlo Park

Anuv Ratan (Menlo Park) joined KKR in 2017 and is a member of the Health Care Strategic Growth team. He currently serves as a director or observer on the boards of Biotage, Cordis, Dawn Biopharma, Gamma Biosciences, Immedica Pharma, Nordic Bioscience, Precipart, Sapphiros, and Zeus Health. He was actively involved in the firm's investments in Aimmune Therapeutics, Ajax Health, Biosynth, Headlands Research, Resolian and Treeline. He also serves on the board and investment committee of HealthCare Royalty Partners. Mr. Ratan was based in London in 2021 and 2022. Prior to joining KKR, he worked at FFL Partners and Blackstone. He holds an A.B. in Neurobiology from Harvard University.